TrialEuropean journal of cancer (Oxford, England : 1990)2020

Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma.

Frede Donskov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.